Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the implementation of its monitoring assignment for global insight of circovirus disease (MAGIC) program, which will assist swine producers and veterinarians in identifying, assessing and monitoring several disease risk factors related to porcine circovirus associated diseases (PCVAD).
Boehringer Ingelheim Vetmedica, Inc., (BIVI) announces the implementation of its monitoring assignment for global insight of circovirus disease (MAGIC) program, which will assist swine producers and veterinarians in identifying, assessing and monitoring several disease risk factors related to porcine circovirus associated diseases (PCVAD).
The program involves a thorough survey of a producer's swine health program and relevant diagnostic screenings, to establish an accurate benchmark for disease status. Results of the MAGIC surveys will help producers and veterinarians implement effective vaccination and disease management protocols not only against PCVAD, but other disease cofactors as well, the company adds. BIVI professional service veterinarians, liaison veterinarians and sales managers will provide the results of the MAGIC assessments and diagnostic tests to producers and veterinarians, as well as make disease management recommendations based on those results.
For fastest response, call
(800) 325-9167